Agents affecting osteolysis in patients with breast cancer.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000150:complications / Q000556:secondary; D001862:Bone Resorption / Q000188:drug therapy*; D001943:Breast Neoplasms / Q000150:complications*; D002116:Calcitonin / Q000627:therapeutic use*; D005260:Female; D005480:Flurbiprofen / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D010014:Osteolysis / Q000188:drug therapy* / Q000209:etiology; D008926:Plicamycin / Q000627:therapeutic use*; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D005480:Flurbiprofen; D002116:Calcitonin; D008926:Plicamycin; D001241:Aspirin; D007213:Indomethacin